Nerve growth factor and the activity of tyrosine hydroxylase in organ cultures of rat superior cervical ganglia

Nerve growth factor increases activity of ornithine decarboxylase in rat brain

Intraventricular administration of nanogram quantities of nerve growth factor to adult rats results in a marked increase in the activity of ornithine decarboxylase (L-ornithine carboxy-lyase, EC 4.1.1.17) in the brain. The increase occurs in all major brain regions and the activity is maximal by 7.5 hr after administration. The enzyme response to nerve growth factor increases in magnitude during maturation; the relative increase in ornithine decarboxylase activity in adult animals is much greater than that in young. Neither insulin nor bovine growth hormone was able to increase ornithine decarboxylase activity to the same extent as did nerve growth factor. When brain was separated into neuronal- and glial-enriched fractions, induction of ornithine decarboxylase was found in both, but a greater increase was observed in the glial fraction.

Forskolin mediates the survival of nerve growth factor-dependent sympathetic neurons of chick embryo by a cyclic AMP-independent mechanism

Forskolin has become an invaluable tool for exploring the involvement of cyclic AMP in a variety of cellular functions. The diterpine directly activates the catalytic subunit of adenylate cyclase, causing a marked increase in cyclic AMP content. Because of this well-characterized action, practically all the observed effects of forskolin are commonly attributed to cyclic AMP-dependent processes. We show here that forskolin exerts a neurotrophic action that is almost identical to that of nerve growth factor (NGF) and phorbol 12,13-dibutyrate (PDB) but independent of cyclic AMP. Sympathetic neurons of the chick embryo supported in culture for 2 days by NGF, forskolin plus 3-isobutyl-1-methylxanthine (IBMX), or PDB had almost identical levels of cyclic AMP (between 9 and 12 pmol/mg protein). Neurons supported in culture for 2 days by NGF or PDB when challenged with forskolin plus IBMX showed almost a 15-fold increase in cyclic AMP, but those supported by forskolin plus IBMX and then exposed to the same combination of drugs did not show an increase in cyclic AMP, exhibiting a marked down-regulation. Exposure of neurons to forskolin for 2 h was ineffective in supporting long-term survival, suggesting that an initial increase in cyclic AMP formation is not sufficient but the continued presence of the drug is essential for survival. Effects of forskolin on the survival of these neurons could be observed even in the presence of dideoxyadenosine, and inhibitor of adenylate cyclase. Neurons supported by PDB for 2 days in culture when exposed to NGF for the first time did not show any increase in cyclic AMP, providing clear evidence that NGF does not affect this second messenger in its target cells. Similarly, neurons supported by NGF for 2 days when exposed to PDB did not show an increase in cyclic AMP.(ABSTRACT TRUNCATED AT 250 WORDS)

The alpha-bungarotoxin site and its relation to the cholinergic and nerve growth factor mediated increases in tyrosine hydroxylase activity in cultures of sympathetic ganglia and chromaffin cells

alpha-Bungarotoxin has been proposed to interact with a membrane site in neuronal tissue which has the characteristics of a nicotinic acetylcholine receptor and also a trophic receptor. A nerve cell function which is affected by both nicotinic stimulation and nerve growth factor is the induction of tyrosine hydroxylase. For this reason, alpha-bungarotoxin was tested on the carbachol-induced increase and nerve growth factor-mediated increase in tyrosine hydroxylase activity in two preparations of neuronal origin, organ cultures of rat superior cervical ganglia and cultured bovine adrenal medullary cells. The results demonstrate that the alpha-bungarotoxin site is not involved in tyrosine hydroxylase induction.

Growth factor dependence of pheochromocytoma cells in chemically defined medium

We have previously described the isolation of a clonal pheochromocytoma cell line (PC-G2) which responds to nerve growth factor (NGF) [Goodman and Herschman, 1978] and epidermal growth factor (EGF) [Goodman et al, 1980] with increased specific activity of tyrosine hydroxylase (TH). This cell line thus can be used for studies of induction of a key enzyme in the biosynthesis of catecholamines using a homogeneous cell population under controlled environmental influences. However, the need for serum in the culture medium used to grow these cells still introduced a lack of total environmental control. Several laboratories have circumvented this problem by growing cells in chemically defined medium. In the present report we demonstrate that with a modification PC-G2 cells can survive and grow in the chemically defined N3 medium devised by Bottenstein and Sato [1979]. While another pheochromocytoma cell line, PC-12, was shown to grow in N3 medium without any supplement [Bottenstein et al, 1979], the PC-G2 cells exhibit an absolute requirement for NGF or EGF in order to grow in this chemically defined medium. As was the case in the induction of TH in serum-containing medium [Goodman and Herschman, 1978; Goodman et al. 1980], EGF was found to be 100 times more potent than NGF in the support of growth of the PC-G2 cells. In the present report we demonstrate not only that either of these growth factors will support the growth of the PC-G2 cells, but also that the relative potency of these two factors for support of the cell growth is similar to their relative potencies in the induction of tyrosine hydroxylase in serum-containing medium.

The receptor-mediated activation of tyrosine hydroxylation in the superior cervical ganglion of the rat

The addition of carbachol to superior cervical ganglia causes a rapid increase in tyrosine hydroxylation in situ. The increase occurs in ganglia from both newborn and adult animals, and in ganglia from animals pretreated with reserpine. The increase is not due to increased transport of the substrate. The increase is dependent upon the presence of calcium, and is additive to the stimulation produced by dibutyryl cyclic AMP. The stimulation seems specific for tyrosine hydroxylation; dopamine beta-hydroxylation is not increased. Preincubation experiments suggest that the carbachol-induced stimulation is due to a change in the availability of, or the affinity of the enzyme for, reduced pterin cofactor. The stimulation is inhibited by atropine and also by low concentrations of phenoxybenzamine or haloperidol, which suggests that it is caused by an action of carbachol on the interneurons in the ganglia.

[Role of cell-milieu interactions in the differentiation of nerve cells]

In this review some aspects of nerve cell development are studied from the point of view of the role of the environment on differentiation processes. In the first part, attention is focused on the early stages, with special emphasis on the commitment of the cells coming from the neural crest to acquire and keep a specialized phenotype. In the second part, attempts were made to understand the mechanisms of action of specific growth factors, the Nerve Growth Factor (NGF) being taken as a model molecule. Information presently available is presented on factors that may be implicated in the development of cell types other than those NGF-sensitive, with considerations as to whether the notion of specific growth factors can be generalized to all nervous cell types or not.

Nerve growth factor: effects on D-amphetamine-induced activity and brain monoamines

Adult male rats were given 6-hydroxydopamine lesions of the nucleus accumbens, followed immediately by injections of saline or nerve growth factor (NGF; 125 B.U.) near the substantia nigra. Such lesions were previously reported to attenuate the locomotor response to D-amphetamine. NGF-treated rats showed an enhanced response to D-amphetamine (1.5 mg/kg) when tested 15 days postoperatively. Levels of dopamine and norepinephrine in the striatum and nucleus accumbens were equivalently depressed in the two lesion groups, indicating that the apparent recovery of the NGF-treated rats was probably not due to catecholaminergic neuronal regrowth. Intracerebral NGF administeration enhanced the response to D-amphetamine 15 days later in rats without lesions, and also appeared to result in increased turnover of brain norepinephrine and serotonin at 3, but not 15, days postadministration. NGF might increase dopamine turnover at 15 days, but the evidence obtained did not convincingly confirm or negate this possibility. The results in brain-damaged and intact rats, and also modify the apparent turnover of brain monoamines.